seed
Stage
1
Investors
About
Ternary Therapeutics is a London-based biotech that designs small-molecule "molecular glue" therapeutics using machine learning and physics-based molecular modelling. Its platform predicts protein "glueability", models binary and ternary protein complexes, assesses complex stability with molecular dynamics, and optimises glue molecules for drug discovery.
Explore Ternary Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.